NCT00130364View on ClinicalTrials.gov

Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

August 31, 2006

Conditions
Atopic Dermatitis
Interventions
DRUG

Pimecrolimus

Pimecrolimus 1 % cream

DRUG

Placebo

Pimecrolimus vehicle cream (placebo)

Trial Locations (1)

Unknown

This study is not being conducted in the United States, Novartis Pharmaceuticals

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY